Cargando…
Review: Radionuclide Molecular Imaging Targeting HER2 in Breast Cancer with a Focus on Molecular Probes into Clinical Trials and Small Peptides
As the most frequently occurring cancer worldwide, breast cancer (BC) is the leading cause of cancer-related death in women. The overexpression of HER2 (human epidermal growth factor receptor 2) is found in about 15% of BC patients, and it is often associated with a poor prognosis due to the effect...
Autores principales: | Ge, Shushan, Li, Jihui, Yu, Yu, Chen, Zhengguo, Yang, Yi, Zhu, Liqing, Sang, Shibiao, Deng, Shengming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588233/ https://www.ncbi.nlm.nih.gov/pubmed/34770887 http://dx.doi.org/10.3390/molecules26216482 |
Ejemplares similares
-
Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by (18)F-FDG PET/CT Radiomics and Clinicopathological Characteristics
por: Li, Jihui, et al.
Publicado: (2021) -
Prognostic value of (18)F-FDG PET/CT radiomic model based on primary tumor in patients with non-small cell lung cancer: A large single-center cohort study
por: Li, Jihui, et al.
Publicado: (2022) -
Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer
por: Jia, Tongtong, et al.
Publicado: (2023) -
D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy
por: Luyten, Kaat, et al.
Publicado: (2021) -
Identification of multiple cardiac metastases from nonsmall-cell lung cancer by (18)F-FDG PET/CT: A case report
por: Deng, Shengming, et al.
Publicado: (2018)